KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Operating Expenses (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Operating Expenses for 17 consecutive years, with $291.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 2.73% to $291.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 billion, a 0.91% increase, with the full-year FY2025 number at $1.1 billion, up 0.9% from a year prior.
  • Operating Expenses was $291.3 million for Q4 2025 at Bio-Rad Laboratories, up from $278.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $300.5 million in Q1 2023 to a low of $244.7 million in Q3 2023.
  • A 5-year average of $277.2 million and a median of $279.3 million in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: rose 23.36% in 2021, then decreased 14.52% in 2022.
  • Bio-Rad Laboratories' Operating Expenses stood at $280.5 million in 2021, then decreased by 1.39% to $276.6 million in 2022, then dropped by 2.04% to $271.0 million in 2023, then grew by 4.64% to $283.6 million in 2024, then increased by 2.73% to $291.3 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Operating Expenses are $291.3 million (Q4 2025), $278.1 million (Q3 2025), and $268.2 million (Q2 2025).